Dealing with FDA can be challenging!!
Have a look at a recent success story of how Asphalion prepared and submitted an IND to FDA for a small European biotech company.
At Asphalion we can assist you with your FDA projects, thanks to our extensive track record of over 20 years.
CLICK HERE TO SEE THE CASE STUDY
For further information you can contact us at: [email protected]
Search News & Events
Share
The Therapeutic Goods Administration (TGA) of Australia has released an updated version of its electronic Common Technical Document (eCTD) Module 1 Specifications, moving from version
As of April 14th, 2025, the new FDA ESG NextGen submission portal has officially launched!!
Join Asphalion and many more Life Science industry experts at EXTEDO’s eRA conference next month in Frankfurt! Our Asphalion team will be exhibiting and speaking
Services
SDGs
As a company committed to sustainability, we follow the UN’s 2030 Agenda and its Sustainable Development Goals.
Memberships & PartnershipS
Quality Management System
Innovative SME
SDGs
As a company committed to sustainability, we follow the UN’s 2030 Agenda and its Sustainable Development Goals.
© Asphalion
Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts.
We will be happy to assist you!
